Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR-positive, HER2-negative advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy☆
Publication date: Available online 24 October 2026 Source: Annals of Oncology Author(s): K. Kalinsky, S.A. Wander, E. Hamilton, S.L. Graff, R. Jeselsohn, K.H. Park, U. Demirci, M. Martin, R.M. Layman, S.A. Hurvitz, S. Sammons, P.A. Kaufman, E. Ravenberg, S. Amdur, L.M. Litchfield, G. Bianchini
Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR-positive, HER2-negative advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426080750?dgcid=rss_sd_all
Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR-positive, HER2-negative advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426080750?dgcid=rss_sd_all
“Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR-positive, HER2-negative advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy☆.” Annals of Oncology.
@article{article36282,
title = {Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR-positive, HER2-negative advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426080750?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...